Stocks and Investing Stocks and Investing
Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018
Wed, February 14, 2018
Tue, February 13, 2018

Liisa Bayko Maintained (VRTX) at Buy with Increased Target to $211 on, Feb 13th, 2018


Published on 2024-10-26 02:56:14 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of JMP Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $200 to $211 on, Feb 13th, 2018.

Liisa has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Liisa


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Friday, February 2nd, 2018
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $197 on, Thursday, February 1st, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $191 on, Thursday, February 1st, 2018
  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $200 on, Thursday, February 1st, 2018